503PEPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer
Moigne, R Le, Banuelos, C A, Mawji, N R, Tam, T, Wang, J, Jian, K, Andersen, R J, Cesano, A, Sadar, M D, Zhou, H -J, Virsik, PVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.065
Date:
October, 2019
File:
PDF, 88 KB
english, 2019